From April 25 to 26,2025, the "Advances in Rheumatology and Immunology Diagnosis and Treatment Workshop" organized by Chengdu High-Tech Medical Association was successfully held.
This event aimed to promote the development of rheumatology and immunology, update knowledge, advance technologies, and optimize clinical practices. It shared the latest basic and clinical research findings while exploring the application of emerging technologies in rheumatology and immunology.
The workshop also facilitated interdisciplinary collaboration to accelerate scientific breakthroughs and enhance precision diagnosis and treatment capabilities This training workshop focused on the latest research findings, technological breakthroughs, and clinical practice optimization in the field of rheumatologic and immunological diseases. Experts, scholars, and clinicians specializing in rheumatology and immunology from across China gathered to map out a new blueprint for industry development through keynote presentations, case discussions, and interdisciplinary dialogues.
The conference delved into the pathogenesis, precision diagnosis, and personalized treatment of rheumatologic and immunological diseases.
Leading experts shared insights on autoimmune disease biomarkers research, clinical applications of targeted therapies, and management of complex cases. By integrating international guidelines with local practices, they provided attendees with practical clinical solutions.
Participants unanimously agreed that interdisciplinary collaboration is crucial for achieving precision diagnosis and treatment as well as comprehensive patient management. They emphasized the need to further strengthen research translation and clinical collaboration networks in the future.
This workshop has established a high-level academic exchange platform for the rheumatology and immunology field, which will continue to promote scientific collaboration, technology dissemination, and standardized diagnosis and treatment practices, ultimately benefiting more patients.
